Pre-existing COPD is associated with an increased risk of mortality and severity in COVID-19: a rapid systematic

Golam Rabbani1, Sheikh Mohammad Shariful Islam2, Muhammad Aziz Rahman3,4

  • 1Bangladesh Betar (Radio), Ministry of Information, Dhaka, Bangladesh.

Insights

Patients with chronic obstructive pulmonary disease (COPD) face over three times the risk of mortality and severe illness from COVID-19. Identifying these individuals early is crucial for timely interventions during the pandemic.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Epidemiology

Background:

  • Pre-existing chronic obstructive pulmonary disease (COPD) is a significant comorbidity.
  • The impact of COPD on COVID-19 outcomes requires thorough investigation.
  • Understanding risk factors for severe COVID-19 is critical for public health.

Purpose of the Study:

  • To systematically review and meta-analyze the association between COPD and COVID-19 mortality.
  • To assess the impact of COPD on the severity of COVID-19 illness.
  • To identify high-risk patient groups for targeted interventions.

Main Methods:

  • Systematic literature search across major databases (Ovid Medline, Embase, PubMed, Scopus) from December 2019 to July 2020.
  • Extraction of studies reporting risk estimates (Hazard Ratio, Risk Ratio) with 95% confidence intervals.
  • Meta-analysis using a random-effects model to calculate pooled estimates for mortality and severity.

Main Results:

  • COVID-19 patients with COPD exhibited a significantly higher risk of mortality (RR 3.18, 95% CI 2.11-4.80).
  • COPD was associated with increased COVID-19 severity (RR 3.63, 95% CI 2.48-5.31).
  • Male patients demonstrated a higher risk of mortality compared to females (RR 1.20, 95% CI 1.12-1.29).

Conclusions:

  • Pre-existing COPD more than triples the risk of mortality and severe outcomes in COVID-19 patients.
  • Early identification of COPD patients is essential for implementing timely interventions.
  • This highlights the need for focused management strategies for COPD patients during pandemics.

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.9K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
555
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.2K